What Researchers Did
This clinical study investigated the effect of hyperbaric oxygen therapy in 21 patients with nonarteritic anterior ischemic optic neuropathy.
What They Found
Of 10 patients in the experimental group who received hyperbaric oxygen after failed corticosteroid treatment, 6 showed significant improvement in visual acuity and field of vision, with further improvement at six months.
In contrast, all patients in the control group, treated solely with corticosteroids, showed no significant improvement in visual acuity or visual field.
What This Means for Canadian Patients
For Canadian patients with nonarteritic anterior ischemic optic neuropathy who do not respond to standard corticosteroid therapy, hyperbaric oxygen may offer a potential alternative treatment option.
This could provide hope for improving visual outcomes in a challenging condition.
Canadian Relevance
This study has no direct Canadian connection as it was conducted outside of Canada.
Study Limitations
A limitation of this study is its small sample size of 21 patients, which may limit the generalizability of the findings.